Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2023

Open Access 01-12-2023 | Osteoporosis | Research

Dietary iron intake and its impact on osteopenia/osteoporosis

Authors: Xin Liu, Jingjing An

Published in: BMC Endocrine Disorders | Issue 1/2023

Login to get access

Abstract

Background

Osteoporosis is a prevalent condition characterized by low bone density and increased risk of fractures, resulting in a significant healthcare burden. Previous research has suggested that serum ferritin levels may be related to the risk of developing osteoporosis. The aim of this study was to investigate the relationship between dietary iron intake and the development of osteoporosis.

Methods

Using data from the National Health and Nutrition Examination Survey (NHANES) conducted between 2005 and 2018, a total of 11,690 adults aged over 20 were evaluated. Bone mineral density (BMD) measurements of the femoral neck and lumbar spine were used to assess osteoporosis and osteopenia. Dietary iron intake was determined using food intake interviews and the Food and Nutrient Database for Dietary Studies. Logistic regression models were applied to investigate the association between dietary iron consumption and osteopenia and osteoporosis.

Results

After adjusting for sociodemographic factors, compared with those who had the first quartile (Q1) of dietary iron intake, the odds ratio (OR) for osteopenia across the quartiles of dietary iron intake levels was 0.88 (95%CI: 0.79–0.98), 0.80 (95%CI: 0.72–0.89), and 0.74 (95%CI: 0.67–0.83) for Q2, Q3, and Q4, respectively. And the OR for osteoporosis across the quartiles of dietary iron intake levels was 1.00, 0.77 (95%CI: 0.50–1.19), 0.54 (95%CI: 0.34–0.89), and 0.83 (95%CI: 0.54–1.29) for Q1, Q2, Q3, and Q4, respectively. Notably, the observed association was significant among females but not males.

Conclusion

The risk of osteopenia/osteoporosis in females decreases with a moderate increase in dietary iron consumption. For females to preserve bone health, moderately increasing their dietary iron intake without overindulging should be seen as a key approach. Our study provides useful insights for developing dietary strategies to prevent and manage osteoporosis in vulnerable populations.
Literature
1.
go back to reference Jandu J, et al. Osteopenia - StatPearls - NCBI Bookshelf. NCBI Bookshelf- StatPearls; 2020. Jandu J, et al. Osteopenia - StatPearls - NCBI Bookshelf. NCBI Bookshelf- StatPearls; 2020.
2.
go back to reference Xu W et al. Risk of osteoporosis and fracture after hysterectomies without oophorectomies: a systematic review and pooled analysis 2022: p. 1–10. Xu W et al. Risk of osteoporosis and fracture after hysterectomies without oophorectomies: a systematic review and pooled analysis 2022: p. 1–10.
3.
go back to reference Liying HE et al. The prevalence rate of osteoporosis in the elderly in China between 2010 and 2016:a metaanalysis of single rate. 2016. Liying HE et al. The prevalence rate of osteoporosis in the elderly in China between 2010 and 2016:a metaanalysis of single rate. 2016.
4.
go back to reference Lahtinen A et al. No major differences in recovery after hip fracture between Home-Dwelling Female and male patients. 2020. 109(3): p. 250–64. Lahtinen A et al. No major differences in recovery after hip fracture between Home-Dwelling Female and male patients. 2020. 109(3): p. 250–64.
5.
go back to reference Si L et al. Projection of osteoporosis-related fractures and costs in China: 2010–2050 2015. Si L et al. Projection of osteoporosis-related fractures and costs in China: 2010–2050 2015.
6.
go back to reference Moran JM. Nutrition and Women’s Bone Health. Nutrients, 2022. 14(4). Moran JM. Nutrition and Women’s Bone Health. Nutrients, 2022. 14(4).
7.
go back to reference Knurick JR, et al. Comparison of correlates of bone mineral density in individuals adhering to lacto-ovo, vegan, or omnivore diets: a cross-sectional investigation. Nutrients. 2015;7(5):3416–26.CrossRefPubMedPubMedCentral Knurick JR, et al. Comparison of correlates of bone mineral density in individuals adhering to lacto-ovo, vegan, or omnivore diets: a cross-sectional investigation. Nutrients. 2015;7(5):3416–26.CrossRefPubMedPubMedCentral
8.
go back to reference Reed JA et al. Comparative changes in radial-bone density of elderly female lacto-ovovegetarians and omnivores. 1994. 59(5 Suppl): p. 1197S. Reed JA et al. Comparative changes in radial-bone density of elderly female lacto-ovovegetarians and omnivores. 1994. 59(5 Suppl): p. 1197S.
9.
go back to reference Ann R, J.T.A.J.o.C M, Nutrition. Bone nutrients for vegetarians. 2014;100(1S):469S–75. Ann R, J.T.A.J.o.C M, Nutrition. Bone nutrients for vegetarians. 2014;100(1S):469S–75.
10.
11.
go back to reference Katsumata SI et al. Dietary Iron Deficiency decreases serum osteocalcin concentration and bone Mineral density in rats. 2006. 70(10): p. 2547–50. Katsumata SI et al. Dietary Iron Deficiency decreases serum osteocalcin concentration and bone Mineral density in rats. 2006. 70(10): p. 2547–50.
12.
go back to reference Denis et al. Iron Deficiency negatively affects vertebrae and femurs of rats independently of Energy Intake and Body Weight1. 2004. 134(11): p. 3061–7. Denis et al. Iron Deficiency negatively affects vertebrae and femurs of rats independently of Energy Intake and Body Weight1. 2004. 134(11): p. 3061–7.
13.
go back to reference Katsumata SI, et al. Severe iron deficiency decreases both bone formation and bone resorption in rats. 2009;139(2):238–43. Katsumata SI, et al. Severe iron deficiency decreases both bone formation and bone resorption in rats. 2009;139(2):238–43.
14.
go back to reference Jia P et al. Ferric ion could facilitate osteoclast differentiation and bone resorption through the production of reactive oxygen species. 2012. 30(11): p. 1843–52. Jia P et al. Ferric ion could facilitate osteoclast differentiation and bone resorption through the production of reactive oxygen species. 2012. 30(11): p. 1843–52.
15.
go back to reference Doyard M et al. Iron excess limits HHIPL-2 gene expression and decreases osteoblastic activity in human MG-63 cells. 2012. 23(10): p. 2435–45. Doyard M et al. Iron excess limits HHIPL-2 gene expression and decreases osteoblastic activity in human MG-63 cells. 2012. 23(10): p. 2435–45.
17.
go back to reference Ahluwalia N et al. update on nhanes dietary data: focus on collection, release, analytical considerations, and uses to inform public policy 1,2 Ahluwalia N et al. update on nhanes dietary data: focus on collection, release, analytical considerations, and uses to inform public policy 1,2
18.
go back to reference You Y, et al. The association between sedentary behavior, exercise, and sleep disturbance: a mediation analysis of inflammatory biomarkers. Front Immunol. 2022;13:1080782.CrossRefPubMed You Y, et al. The association between sedentary behavior, exercise, and sleep disturbance: a mediation analysis of inflammatory biomarkers. Front Immunol. 2022;13:1080782.CrossRefPubMed
19.
go back to reference Rahman HH et al. Association of albumin to creatinine ratio with urinary arsenic and metal exposure: evidence from NHANES 2015–2016 2022(54 – 6). Rahman HH et al. Association of albumin to creatinine ratio with urinary arsenic and metal exposure: evidence from NHANES 2015–2016 2022(54 – 6).
20.
go back to reference Naimi TS et al. Binge Drinking Among US Adults 2003. 289(1). Naimi TS et al. Binge Drinking Among US Adults 2003. 289(1).
21.
22.
go back to reference Ainsworth et al. Compendium of physical activities: classification of energy costs of human physical activities. 1993. 93(6): p. 710–0. Ainsworth et al. Compendium of physical activities: classification of energy costs of human physical activities. 1993. 93(6): p. 710–0.
23.
go back to reference Seidell JC, et al. Obesity and fat distribution in relation to health -. Curr insights recommendations. 1987;50:57. Seidell JC, et al. Obesity and fat distribution in relation to health -. Curr insights recommendations. 1987;50:57.
25.
go back to reference Wang T, et al. Therapeutic potential and Outlook of Alternative Medicine for osteoporosis. Curr Drug Targets. 2017;18(9):1051–68.CrossRefPubMed Wang T, et al. Therapeutic potential and Outlook of Alternative Medicine for osteoporosis. Curr Drug Targets. 2017;18(9):1051–68.CrossRefPubMed
26.
go back to reference He J, et al. Therapeutic anabolic and anticatabolic benefits of Natural Chinese Medicines for the treatment of osteoporosis. Front Pharmacol. 2019;10:1344.CrossRefPubMedPubMedCentral He J, et al. Therapeutic anabolic and anticatabolic benefits of Natural Chinese Medicines for the treatment of osteoporosis. Front Pharmacol. 2019;10:1344.CrossRefPubMedPubMedCentral
27.
go back to reference Trautvetter U, et al. Effect of calcium phosphate and vitamin D(3) supplementation on bone remodelling and metabolism of calcium, phosphorus, magnesium and iron. Nutr J. 2014;13:6.CrossRefPubMedPubMedCentral Trautvetter U, et al. Effect of calcium phosphate and vitamin D(3) supplementation on bone remodelling and metabolism of calcium, phosphorus, magnesium and iron. Nutr J. 2014;13:6.CrossRefPubMedPubMedCentral
28.
go back to reference Mahdavi-Roshan M, Ebrahimi M, Ebrahimi A. Copper, magnesium, zinc and calcium status in osteopenic and osteoporotic post-menopausal women. Clin Cases Miner Bone Metab. 2015;12(1):18–21.PubMedPubMedCentral Mahdavi-Roshan M, Ebrahimi M, Ebrahimi A. Copper, magnesium, zinc and calcium status in osteopenic and osteoporotic post-menopausal women. Clin Cases Miner Bone Metab. 2015;12(1):18–21.PubMedPubMedCentral
29.
go back to reference Alonso N, et al. Role of vitamin K in bone and muscle metabolism. Calcif Tissue Int. 2023;112(2):178–96.CrossRefPubMed Alonso N, et al. Role of vitamin K in bone and muscle metabolism. Calcif Tissue Int. 2023;112(2):178–96.CrossRefPubMed
30.
go back to reference Lisco G, et al. Endocrine, metabolic, and Immune Pathogenesis of Postmenopausal osteoporosis. Is there a therapeutic role in Natural Products? Endocr Metab Immune Disord Drug Targets; 2023. Lisco G, et al. Endocrine, metabolic, and Immune Pathogenesis of Postmenopausal osteoporosis. Is there a therapeutic role in Natural Products? Endocr Metab Immune Disord Drug Targets; 2023.
31.
32.
go back to reference Wei M, et al. Manganese, iron, copper, and selenium co-exposure and osteoporosis risk in chinese adults. J Trace Elem Med Biol. 2022;72:126989.CrossRefPubMed Wei M, et al. Manganese, iron, copper, and selenium co-exposure and osteoporosis risk in chinese adults. J Trace Elem Med Biol. 2022;72:126989.CrossRefPubMed
33.
go back to reference Guggenbuhl P et al. Bone mineral density in men with genetic hemochromatosis and HFE gene mutation. 2005. 16(12): p. 1809–14. Guggenbuhl P et al. Bone mineral density in men with genetic hemochromatosis and HFE gene mutation. 2005. 16(12): p. 1809–14.
34.
go back to reference Pan ML et al. Iron Deficiency Anemia as a Risk Factor for Osteoporosis in Taiwan: A Nationwide Population-Based Study 2017(6). Pan ML et al. Iron Deficiency Anemia as a Risk Factor for Osteoporosis in Taiwan: A Nationwide Population-Based Study 2017(6).
35.
go back to reference Lorenc R, et al. Guidelines for the diagnosis and management of osteoporosis in Poland: Update 2017. Endokrynol Pol. 2017;68(5):604–9.CrossRefPubMed Lorenc R, et al. Guidelines for the diagnosis and management of osteoporosis in Poland: Update 2017. Endokrynol Pol. 2017;68(5):604–9.CrossRefPubMed
36.
go back to reference Lee KS et al. Serum ferritin levels are positively associated with bone mineral density in elderly Korean men: the 2008–2010 Korea National Health and Nutrition Examination Surveys 2014. 32(6). Lee KS et al. Serum ferritin levels are positively associated with bone mineral density in elderly Korean men: the 2008–2010 Korea National Health and Nutrition Examination Surveys 2014. 32(6).
37.
go back to reference Iron overload accelerates bone loss in healthy postmenopausal women and middle-aged men: a 3 year retrospective longitudinal study %J J Bone Miner Res. 2012. 27. Iron overload accelerates bone loss in healthy postmenopausal women and middle-aged men: a 3 year retrospective longitudinal study %J J Bone Miner Res. 2012. 27.
38.
go back to reference Organization WH. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO study group [meeting held in Rome from 22 to 25 June 1992] 1994. Organization WH. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO study group [meeting held in Rome from 22 to 25 June 1992] 1994.
39.
go back to reference Siris ES, et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National. Osteoporos Risk Assess. 2001;286(22):2815–22. Siris ES, et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National. Osteoporos Risk Assess. 2001;286(22):2815–22.
41.
go back to reference Che J, et al. The Effect of Abnormal Iron Metabolism on Osteoporosis. 2020;195(2):353–65. Che J, et al. The Effect of Abnormal Iron Metabolism on Osteoporosis. 2020;195(2):353–65.
42.
go back to reference Vasta JD, Raines RT. Human collagen prolyl 4-Hydroxylase is activated by ligands for its Iron Center. Biochemistry. 2016;55(23):3224–33.CrossRefPubMed Vasta JD, Raines RT. Human collagen prolyl 4-Hydroxylase is activated by ligands for its Iron Center. Biochemistry. 2016;55(23):3224–33.CrossRefPubMed
43.
go back to reference Suokas M, et al. Retrieval-independent localization of lysyl hydroxylase in the endoplasmic reticulum via a peptide fold in its iron-binding domain. Biochem J. 2003;370(Pt 3):913–20.CrossRefPubMedPubMedCentral Suokas M, et al. Retrieval-independent localization of lysyl hydroxylase in the endoplasmic reticulum via a peptide fold in its iron-binding domain. Biochem J. 2003;370(Pt 3):913–20.CrossRefPubMedPubMedCentral
44.
go back to reference Shoulders M, R.T.J.A.R.o B, Raines. Collagen Struct Stab. 2010;78(1):929–58. Shoulders M, R.T.J.A.R.o B, Raines. Collagen Struct Stab. 2010;78(1):929–58.
45.
go back to reference Wang P et al. The burgeoning role of cytochrome P450-mediated vitamin D metabolites against colorectal cancer. 2018. 133: p. 9–20. Wang P et al. The burgeoning role of cytochrome P450-mediated vitamin D metabolites against colorectal cancer. 2018. 133: p. 9–20.
46.
go back to reference Gil A, et al. Vitam D: Classic Novel Actions. 2018;72(2):87. Gil A, et al. Vitam D: Classic Novel Actions. 2018;72(2):87.
47.
go back to reference Wang et al. Iron overload increases osteoclastogenesis and aggravates the effects of ovariectomy on bone mass 2015. Wang et al. Iron overload increases osteoclastogenesis and aggravates the effects of ovariectomy on bone mass 2015.
48.
go back to reference Kular J, et al. An overview of the regulation of bone remodelling at the cellular level. Clin Biochem. 2012;45(12):863–73.CrossRefPubMed Kular J, et al. An overview of the regulation of bone remodelling at the cellular level. Clin Biochem. 2012;45(12):863–73.CrossRefPubMed
50.
go back to reference Lu W, et al. Free iron catalyzes oxidative damage to hematopoietic cells/mesenchymal stem cells in vitro and suppresses hematopoiesis in iron overload patients. Eur J Haematol. 2013;91(3):249–61.CrossRefPubMed Lu W, et al. Free iron catalyzes oxidative damage to hematopoietic cells/mesenchymal stem cells in vitro and suppresses hematopoiesis in iron overload patients. Eur J Haematol. 2013;91(3):249–61.CrossRefPubMed
Metadata
Title
Dietary iron intake and its impact on osteopenia/osteoporosis
Authors
Xin Liu
Jingjing An
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2023
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-023-01389-0

Other articles of this Issue 1/2023

BMC Endocrine Disorders 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.